Lopamudra Roy

Lopamudra

All articles by Lopamudra Roy

  1. Gates Foundation supports development of Immunocore’s therapeutics for infectious diseases

    Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble…
    Read More…

    18 Sep
  2. NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells

    A new study conducted by researchers from the National University of Singapore (NUS) has revealed that the co-treatment using artemisinin…
    Read More…

    18 Sep
  3. Teva to sell assets in global women’s health business for $1.38bn

    Teva Pharmaceutical Industries has entered two agreements to divest the remaining stake in its specialist global women’s health business for…
    Read More…

    18 Sep
  4. GSK and Innoviva receive positive opinion from CHMP for Trelegy Ellipta to treat COPD

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for marketing…
    Read More…

    17 Sep
  5. Bristol-Myers and Halozyme to develop subcutaneous immuno-oncology drugs

    Bristol-Myers Squibb has entered a global collaboration and licence agreement to use Halozyme Therapeutics’ Enhanze drug-delivery technology for the development…
    Read More…

    14 Sep
  6. Evotec and MaRS Innovation launch new drug-discovery partnership

    German company Evotec and Canada-based MaRS Innovation (MI) have launched a joint partnership ‘LAB150’ in Toronto, Ontario, Canada. The five-year…
    Read More…

    14 Sep
  7. Fujifilm opens new cell culture process development laboratories in UK

    Fujifilm Diosynth Biotechnologies has opened new and advanced 10,000ft² cell culture process development laboratories in Wilton Centre, Teesside, UK. The…
    Read More…

    13 Sep
  8. Monopar receives licence to develop Onxeo’s Validive oral mucositis treatment

    Onxeo has granted a global exclusive licence to Monopar Therapeutics for its Validive (clonidine mucoadhesive buccal) tablet used to treat…
    Read More…

    13 Sep
  9. US FDA advisory committee votes for GSK’s Shingrix to prevent shingles

    The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted unanimously for GlaxoSmithKline’s…
    Read More…

    13 Sep
  10. Janssen to stop further development of JNJ-4178 hepatitis C treatment

    Janssen Sciences Ireland has taken a strategic decision to discontinue further development of its investigational regimen JNJ-4178 for the treatment…
    Read More…

    12 Sep